Contact Us

New Hope for Peripheral Neuropathy & CRPS Patients

Newbridge Spine & Pain Physician Chirag Sanghvi, M.D. brings state-of-the-art St Jude Medical device to Frederick and Leesburg patients.
  • <strong>Chirag Sanghvi, M.D.</strong>
  • <strong>Dorsal Root Ganglion Therapy - Photo Credit St. Jude Medical</strong>
  • <strong>Newbridge Spine & Pain Center - Interventional Pain Management</strong>

"This treatment will transform the lives of many patients. Patients who have difficulty completing simple daily errands will now benefit from stable long-term pain relief, " states Dr. Sanghvi

    FREDERICK, MD, October 07, 2017 /24-7PressRelease/ -- Dr. Chirag Sanghvi is one of the leading physicians at Newbridge Spine & Pain Center, an interventional pain management group with four locations surrounding Greater Washington D.C.

Dr. Chirag Sanghvi is one of only a handful of specialist pain management physicians to receive training from Abbott, formerly St. Jude Medical, on a revolutionary neuromodulation therapy called DRG (Dorsal Root Ganglion) Therapy. The Axium Neurostimulator is the only FDA-approved system that stimulates the DRG specifically.

Similar to the Spinal Cord Stimulator pain sensations are modified and regulated to reduce pain, however, DRG therapy more accurately targets the specific area of pain in the lower extremities; including the, foot, knee, hip and groin. According to St. Jude Medical the DRG allows for selective stimulation without activating the non-painful neurons, "the unique physiology of the DRG makes stimulation highly selective and steerable."

DRG therapy is especially effective for patients with Chronic pain, usually defined as pain lasting longer than six months, for whom other pain treatments have not worked.

Good candidates for the DRG procedure include patients suffering from Peripheral Neuropathy (including Diabetic Neuropathy) and those diagnosed with Complex Regional Pain Syndrome (CRPS/RSD).

"This treatment will transform the lives of many patients. Patients who have difficulty completing simple daily errands or going for an evening walk will now benefit from stable long-term pain relief with DRG," states Dr. Chirag Sanghvi.

Dr. Sanghvi is a board-certified Pain Specialist and has performed spinal cord stimulation trials and permanent implants for many back pain patients. Although extremely successful for many he is well aware of the limitations SCS has for those with pain below the hips. "DRG offers very promising results for those with pain below the hip, I'm thrilled we finally have a targeted option for these patients," he continues.

Patients with constant pain in the hip, groin, foot or knee, (also known as; chronic intractable pain) are encouraged to contact the Frederick or Leesburg offices of Newbridge Spine & Pain Center to assess if they are a candidate for DRG.

Newbridge Spine & Pain Center is staffed with ABA board-certified Anesthesiologists sub-specialized in interventional pain management. With 4 state-of-the-art facilities in Leesburg, VA, Frederick, Waldorf and Prince Frederick, Maryland.

Newbridge has helped thousands of patients experience effective, long-lasting relief from acute and chronic pain. By incorporating powerful, sophisticated and minimally-invasive pain-relieving treatments into customized plans of care, our pain specialists provide patients the ability to return to an active and healthy lifestyle.

Additional information is available at www.NewbridgeSpine.com.


# # #

Read more Press Releases from Rose Alexander:


Comment on this story...

Share This Story


Email this Story

Contact Information


Rose Alexander
Newbridge Spine & Pain Center

Frederick, MD
United States
Voice: 301-668-9988
E-Mail: Email Us Here
Website: Visit Our Website
Blog: Visit Our Blog
Follow Us:

Like This Story?


I like it! 0

Disclaimer


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.